Ernährung & Medizin 2017; 32(04): 171-175
DOI: 10.1055/s-0043-118118
praxis
Haug Verlag in Georg Thieme Verlag KG Stuttgart

Reizdarmsyndrom und Ernährung: Reizende Diagnose und Therapie!

Christiane Schäfer
Allergologische Schwerpunktpraxis, Team Ernährung
› Author Affiliations
Further Information

Publication History

Publication Date:
19 December 2017 (online)

Mit Veröffentlichung der ROME-IV-Kriterien für die Diagnose des Reizdarmsyndroms (RDS) wächst die bittere Erkenntnis, dass einfache Lösungen bei der Diagnostik und Therapie dieses Krankheitsbilds unmöglich sind. Neben immer komplizierteren Diagnosealgorithmen, die zum Ausschluss anderer pathologischer Zustände abgearbeitet werden müssen, besteht bei den Therapieoptionen Bedarf für eine bessere interdisziplinäre Zusammenarbeit.

 
  • Literatur

  • 1 Andresen V, Keller J, Pehl C. et al. Irritable bowel syndrome – the main recommendations. Dtsch Arztebl Int 2011; 108: 751-760
  • 2 Barbara G, Feinle-Bisset C, Ghoshal U. et al. Intestinal microenvironment and functional gastrointestinal disorders. Gastroenterology 2016; 150: 1305-1318
  • 3 Becker SR, Weber MA. Ballaststoffe. Schweiz Zschr GanzheitsMedizin 2002; 1: 32-40
  • 4 Boeckxstaens G, Camilleri M, Sifrim D. et al. Fundamentals of neurogastroenterology: physiology/motility – sensation. Gastroenterology 2016; 150: 1292-1304
  • 5 Bohn L, Storsrud S, Liljebo T. et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: A randomized controlled trial. Gastroenterology 2015; 149: 1399-1407
  • 6 Brouns F, Delzenne N, Gibson G. The dietary fibers–FODMAPs controversy. Cereal Foods World 2017; 62: 98-103
  • 7 Buhner S, Qin L, Vignali S. et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009; 137: 1425-1434
  • 8 Camilleri M, Boeckxstaens G. Dietary and pharmacological treatment of abdominal pain in IBS. Gut 2017; 66: 966-974
  • 9 Camilleri M, Buéno L, Andresen V. et al. Pharmacologic, pharmacokinetic, and pharmacogenomic aspects of functional gastrointestinal disorders. Gastroenterology 2016; 150: 1319-1331
  • 10 Chey W, Whelan K. Dietary guidelines for irritable bowel syndrome are important for gastroenterologists, dietitians and people with irritable bowel syndrome. J Human Nutr Diet 2016; 29: 547-548
  • 11 Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterology 2016; 150: 1262-1279
  • 12 Edlinger E, Schilling B. Die FODMAP-Ernährungstherapie bei funktionellen Darmerkrankungen. Ernährung und Medizin 2017; 32: 117-118
  • 13 Elsenbruch S, Enck P. Placebo effects and their determinants in gastrointestinal disorders. Nat Rev Gastroenterol Hepatol 2015; 12: 472-485
  • 14 Enck P, Aziz Q, Barbara G. et al. Irritable bowel syndrome. Nat Rev Dis Primers 2016; 24: 16014
  • 15 Enck P, Klosterhalfen S, Weimer K. Unsolved, forgotten, and ignored features of the placebo response in medicine. Clin Ther 2017; 39: 458-468
  • 16 Enck P, Mazurak N. Nichtmedikamentöse Therapie des Reizdarmsyndroms. Gastroenterologe 2017; 12: 141-149
  • 17 Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol 2013; 108: 718-727
  • 18 Federici E, Prete R, Lazzi C. et al. Bacterial composition, genotoxicity, and cytotoxicity of fecal samples from individual consuming omnivorous or vegetarian diet. Front Microbiol 2017; 8: 300
  • 19 Ford AC, Talley NJ, Spiegel BM. et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008; 337: a2313
  • 20 Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: Time for reappraisal. Lancet 1994; 344: 39-40
  • 21 Frieling T, Krummen B, Kalde S. Ernährung bei Störung der Verdauungsfunktionen. Ernährung und Medizin 2017; 32: 119-122
  • 22 Frieling T. Reizdarmsyndrom. Falk Foundation M6 1-8/2017PoP
  • 23 Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol 2010; 25: 252-258
  • 24 Haller D, Hörmannsperger G. Darmgesundheit und Mikrobiom. In: Haller D, Grune T, Rimbach G. Hrsg. Biofunktionalität der Lebensmittelinhaltsstoffe. Berlin, Heidelberg: Springer Spektrum; 2013: 67-83 281-286
  • 25 Halmos EP, Christophersen CT, Bird AR. et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015; 64: 93-100
  • 26 Halmos EP, Christophersen CT, Bird AR. et al. Consistent prebiotic effect on gut microbiota with altered FODMAP intake in patients with Crohn’s disease: A randomised, controlled cross-over trial of well-defined diets. Clin Transl Gastroenterol 2016; 7: e164
  • 27 Houghton LA, Heitkemper M, Crowell M. et al. Age, gender and women’s health and the patient. Gastroenterology 2016; 150: 1332-1343
  • 28 Keefer L, Drossman DA, Guthrie E. et al. Centrally mediated disorders of gastrointestinal pain. Gastroenterology 2016; 150: 1408-1419
  • 29 Layer P, Andresen V, Pehl C. et al. Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management. Z Gastroenterol 2011; 49: 237-293
  • 30 Lebwohl B, Cao Y, Zong G. et al. Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study. BMJ 2017; 357: j1892
  • 31 Lewis JD, Abreu MT. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology 2017; 152: 398-414
  • 32 Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721
  • 33 Malfertheiner P. Was ist eine gute Mikrobiota?. DGVS 15.9.2017
  • 34 Major G, Pritchard S, Murray K. Colon hypersensitivity to distension, rather than excessive gas production produces carbohydrate-related symptoms in individuals with irritable bowel syndrome. Gastroenterology 2017; 152: 124-133
  • 35 Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 2016; 55: 897-906
  • 36 Mazurak N, Broelz E, Storr M, Enck P. Probiotic therapy of the irritable bowel syndrome: Why is the evidence still poor and what can be done about it?. J Neurogastroenterol Motil 2015; 21: 471-485
  • 37 Pedersen N, Andersen NN, Vegh Z. et al. Ehealth: Low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol 2014; 20: 16215-16226
  • 38 Peters SL, Yao CK, Philpott H. et al. Randomised clinical trial: The efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2016; 44: 447-459
  • 39 Salazar N, Dewulf EM, Neyrinck AM. et al. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clin Nutr 2015; 34: 501-507
  • 40 Schäfer C. Food intolerances caused by enzyme defects and carbohydrate malassimiliations: Lactose intolerance and Co. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz 2016; 59: 764-770
  • 41 Schäfer C. Reizender Darm. Hilfestellungen für den Beratungsalltag Ernährung im Fokus 2010; 9: 410-413
  • 42 Schemann M. Reizdarm und Reizmagen – Pathophysiologie und Biomarker. Der Gastroenterologe 2017; 12: 114-129
  • 43 Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil 2017; 23: 151-163
  • 44 Schulze-Lohmann P. Ballaststoffe. ErnährungsUmschau 2012; 59: 408-417
  • 45 Shen NT. Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: a systematic review with meta-regression analysis. Gastroenterology 2017; 152: 1889-1900
  • 46 Shepherd SJ, Parker FC, Muir JG, Gibson PR. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: Randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008; 6: 765-771
  • 47 Stanghellini V, Chan FK, Hasler WL. et al. Gastroduodenal disorders. Gastroenterology 2016; 150: 1380-1392
  • 48 Van Oudenhove L, Crowell MD, Drossmann DA. et al. Biopsychosocial aspects of functional gastrointestinal disorders: how central and environmental processes contribute to the development and expression of functional gastrointestinal disorders. Gastroenterology 2016; 150: 1355-1367